ImmPACT Bio Announces California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases

ImmPACT Bio Announces Opening of California-Based GMP Facility
May 21, 2023 | Biotech Cleanroom Industry, Cleanroom Blog, Cleanroom Industry News, CLEANROOM NEWS FEATURE, Energy Industry, Life Sciences Cleanroom Industry, Materials Science News, Medical Cleanroom Industry, Medical Device Cleanroom Industry, Nanotechnology Clean Room Industry, Optical Clean Room Industry, Pharmaceutical Cleanroom Industry, Pharmacy News, R&D Cleanroom Industry, Semiconductor Clean Room Industry, Sterile Packaging Industry